In-Ho Kim

19PUBLICATIONS
122CO-AUTHORS
South-East Asian languages (excl. Indonesian)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 07, 2026
Agreement, Compliance, and Practice Change of the Korean Practice Guidelines for Gastric Cancer 2022: A Nationwide Multidisciplinary Survey.

|Jun 01, 2026
EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.

|Jul 09, 2025
Patients' Preferences for Gastric Cancer Treatment: A Cross-Sectional Study on Decision-Making in Multidisciplinary Treatment Strategies.

Tae-Han Kim, In-Ho Kim, Seung Joo Kang

|Jan 27, 2025
Exploring the efficacy of fluorouracil and platinum based chemotherapy in advanced hepatocellular carcinoma to bridge the treatment gap in resource limited settings.

Se Jun Park, Kabsoo Shin, In-Ho Kim

|Jan 17, 2025
Conversion Therapy for Stage IV Gastric Cancer: Report From the Expert Consensus Meeting at KINGCA WEEK 2024.

Tae-Han Kim, Ichiro Uyama, Sun Young Rha

|Jan 17, 2025
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).

In-Ho Kim, Seung Joo Kang, Wonyoung Choi

Pageof 4

Frequent Collaborators

7 joint publications

Hye-Sook Han

6 joint publications

Tae-Han Kim

5 joint publications

Kabsoo Shin

5 joint publications

Seung Joo Kang